CAS number: 3223-07-02
General information about the Melphalan Hydrochloride active pharmaceutical ingredient
Melphalan Hydrochloride as active pharmaceutical ingredient (API) is an alkylating agent used to treat multiple myeloma, ovarian carcinoma, uveal melanoma with unresectable hepatic metastases. Melphalan Hydrochloride is a medication used for high-dose conditioning before hematopoietic stem cell transplant in patients. Melphalan Hydrochloride is also indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. Melphalan Hydrochloride comes as oral tablets and injectable solution.
Axplora manufactures Melphalan Hydrochloride API
Melphalan Hydrochloride API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Melphalan Hydrochloride API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Melphalan Hydrochloride API is commercially available as standard grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Melphalan Hydrochloride API.
- Therapeutic area Cytotoxics
- Available grade Standard
- Produced in GRO